Selenium and the thioredoxin redox system: Effects on cell growth and death

Oncology Research

Volumn 9, Issue 6-7, 1997, Pages 303-312

  Powis, Garth ^a   Gasdaska, John R ^a   Gasdaska, Pamela Y ^a   Berggren, Margareta ^a   Lynn Kirkpatrick, D ^a   Engman, Lars ^a   Cotgreave, Ian A ^a   Angulo, Miguel ^a   Baker, Amanda ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Apoptosis; Selenium; Thioredoxin; Thioredoxin reductase

Indexed keywords

SELENIUM; THIOREDOXIN; THIOREDOXIN REDUCTASE;

APOPTOSIS; CELL DEATH; CELL DIVISION; DRUG EFFECT; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DEATH; CELL DIVISION; HUMANS; OXIDATION-REDUCTION; SELENIUM; SIGNAL TRANSDUCTION; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH);

EID: 0031299117     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Karplus, P. A.; Schulz, G. E. Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: Substrate crystal structures at 2A resolution. J. Mol. Biol. 210: 163-180; 1989.
2. Hickman, J. A.; Potten, C. S.; Merrill, A. J.; Fisher, T. C. Apoptosis and cancer chemotherapy. Philos. Trans. R. Soc. Lond. Series B: Biol. Sci. 345:319-325; 1994.
3. Bedi, A.; Pasricha, P. J.; Akhtar, A. J.; Barber, J. P.; Bedi, G. C.; Giardiello, F. M.; Zehnbauer, B. A.; Hamilton, S. R.; Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1811-1816; 1995.
4. Golczewski, J. A.; Frenkel, G. D. Cellular selenoproteins and the effects of selenite on cell proliferation. Biol. Trace Element Res. 20:115-126; 1989.
5. Hu, Y. Studies on the correlation of blood selenium and lung cancer. II An analysis of serum selenium levels and influencing factors in patients with lung cancer. Chin. J. Oncol. 14: 346-349; 1993.
6. Lange, J. H. Reanalysis of epidemiological data for selenium anti-cancer activity. Toxicol. Ind. Health 7:319-325; 1991.
7. Yang, G. Q.; Wang, S. Z.; Zhou, R. H.; Sun, S. Z. Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 37:872-881; 1983.
8. Clark, L. C.; Combs, J. J., Jr.; Turnbull, B. W.; Slate, E. H.; Chalker, D. K.; Chow, J.; Davis, L. S.; Glover, R. A.; Graham, G. F.; Gross, E. G.; Krongrad, A.; Lesher, J. L.; Park, H. K.; Sanders, B. B., Jr.; Smith, C. L.; Taylor, J. R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized clinical trial. J. Am. Med. Assoc. 276:1957-1963; 1996.
9. Stadtman, T. C. Selenocysteine. Annu. Rev. Biochem. 65:83100; 1996.
10. Milner, J. A. Effect of selenium on virally induced and transplantable tumor models. Fed. Proc. 44:2568-2572; 1985.
11. Gasdaska, P.; Oblong, J. E.; Powis, G. Cloning and expression of thioredoxin (T) cDNA from human colon cancer cells. Identity with ADF and levels of T mRNA in human tumors. Proc. Am. Assoc. Cancer Res. 34:62; 1993.
12. Oblong, J. E.; Gasdaska, P. Y.; Sherrill, K.; Powis, G. Purification of human thioredoxin reductase: Properties and characterization by absorption and circular dichroism spectroscopy. Biochemistry 32:7271-7277; 1993.
13. Gasdaska, P. Y.; Gasdaska, J. R.; Cochran, S.; Powis, G. Cloning and sequencing of human thioredoxin reductase. FEBS Lett. 373:5-9; 1995.
14. Gasdaska, J. R.; Gasdaska, P. Y.; Gallegos, A.; Powis, G. Human thioredoxin reductase gene localization to chromosomal position 12q23 - 6q24.1 and mRNA distribution in human tissue. Genomics 37:257-259; 1996.
15. Tamura, T.; Stadtman, T. C. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties, and thioredoxin reductase activity. Proc. Natl. Acad. Sci. USA 93: 1006-1011; 1996.
16. Gladyshev, V. N.; Jeang, K.; Stadtman, T. C. Selenocysteine, identified as the penultimate C-terminal residue in human Tcell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA 93:6146-6174; 1996.
17. Paine, G. D.; Taylor, C. W.; Curtis, R. A.; Lopez, M. H. A.; Dorr, R. T.; Roe, D.; Funk, C. Y.; Thompson, F.; Hersh, E. M. Human tumor models in the severe combined immunue deficient seid mouse. Cancer Chemother. Pharmacol. 40:209-214; 1997.
18. DePalo, D.; Kinlaw, W. B.; Zhao, C.; Engelberg-Kulka, H.; St. Germain, D. L. Effect of selenium deficiency on type I 5′-deodinase. J. Biol. Chem. 269:16223-16228; 1994.
19. Berry, M. J.; Harney, J. W.; Ohama, T.; Hatfield, D. L. Selenocysteine insertion or termination: Factors affecting UGA codon fate and complementary anticodomcodon mutations. Nucleic Acids Res. 22:3753-3759; 1994.
20. Bachur, N. R.; Gordon, S. L.; Gee, M. V.; Kon, H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA 76:954-957; 1979.
21. Low, S. C.; Berry, M. J. Knowing when not to stop: Selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21:203-207; 1996.
22. McCaughan, K. K.; Brown, C. M.; Dalphin, M. E.; Berry, M. J.; Täte, W. P. Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc. Natl. Acad. Sci. USA 92:5431-5435; 1995.
23. Berggren, M.; Gallegos, A.; Gasdaska, J.; Powis, G. Cellular thioredoxin reductase activity is regulated by selenium. Anticancer Res. (in press).
24. Baker, R. D.; Baker, S. S.; LaRosa, K.; Whitney, C.; Newburger, P. E. Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B. Arch. Biochem. Biophys. 304:53-57; 1993.
25. Berry, M. J.; Larsen, P. R. The role of selenium in thyroid hormone action. Endocr. Rev. 13:207-219; 1992.
26. Tanaka, H. O.; Stadtman, T. C. Selenium-dependent clostridial glycine reductase-purification and characterization of the two membrane-associated protein components. J. Biol. Chem. 254:447-452; 1979.
27. Nelson, R. L.; Davis, F. G.; Suiter, E.; Kikendall, J. W.; Sobin, L. H.; Milner, J. A.; Bowen, P. E. Serum selenium and colonie neoplastic risk. Dis. Colon Rectum 38:1306-1310; 1995.
28. Holmgren, A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264:13963-13966; 1989.
29. Luthman, M.; Holmgren, A. Rat liver thioredoxin and thioredoxin reductase: Purification and characterization. Biochem. 21:6628-6633:1982.
30. Gasdaska, P. Y.; Oblong, J. E.; Cotgreave, I. A.; Powis, G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): Thioredoxin mRNA is elevated in some human tumors. Biochim. Biophys. Acta 1218:292-296; 1994.
31. Laurent, T. C.; Moore, E. C.; Reichard, P. Enzymatic synthesis of deoxyribonucleotides VI. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239:3436-3444; 1964.
32. Matthews, J. R.; Wakasugi, N.; Virelizier, J.-L.; Yodoi, J.; Hay, R. T. Thioredoxin regulates the DNA binding activity of NF-kappaB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:3821-3830; 1992.
33. Grippo, J. F.; Tienrungroj, W.; Dahmer, M. K.; Housley, P. R.; Pratt, W. B. Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 258:13658-13664; 1983.
34. Abate, C.; Patel, L.; Rauscher, F. J., Ill; Curran, T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-1161; 1990.
35. Powis, G.; Oblong, J. E.; Gasdaska, P. Y.; Berggren, M.; Hill, S.; Kirkpatrick, D. L. The thioredoxin/thioredoxin reductase redox system and control of cell growth. Oncol. Res. 6:539-544; 1994.
36. Oblong, J. E.; Berggren, M.; Gasdaska, P. Y.; Powis, G. Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J. Biol. Chem. 269:11714-11720; 1994.
37. Gasdaska, J. R.; Hill, S. R.; Kirkpatrick, L.; Montfort, W.; Weichsel, A.; Kuperis, M.; Berggren, M.; Powis, G. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys71 - Ser mutation. Biochem. Pharmacol. 52:1741-1747; 1996.
38. Weichsel, A.; Gasdaska, J. R.; Powis, G.; Montfort, W. R. Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for a regulatory homodimer. Structure 4:735-751; 1996.
39. Gasdaska, J. R.; Berggren, M.; Powis, G. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ. 6:1643-1650; 1995.
40. Kitaoka, Y.; Sorachi, K.; Nakamura, H.; Masutani, H.; Mitsui, A.; Kobayashi, F.; Mori, T.; Yodoi, J. Detection of adult T-cell leukemia-derived factor/human thioredoxin in human serum. Immunol. Lett. 41:155-161; 1994.
41. Berggren, M.; Gallegos, A.; Gasdaska, J. R.; Gasdaska, P. Y.; Warneke, J.; Powis, G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res. 16:3459-3466; 1996.
42. Gallegos, A.; Gasdaska, J. R.; Taylor, C. W.; PaineMurrieta, G. D.; Goodman, D.; Gasdaska, P. Y.; Berggren, M.; Briehl, M. M.; Powis, G. Transfection with human thioredoxin increases cell proliferation and a dominant negative mutant thioredoxin reverses the transformed phenotype of breast cancer cells: Cancer Res. 56:5765-5770; 1996.
43. Kondo, Y.; Woo, E.; Michalska, A. E.; Choo, A. C.; Lazo, J. S. Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res. 55:2021-2023; 1995.
44. Lam, M.; Dubyak, G.; Chen, L.; NuZez, G.; Miesfeld, R. L.; Distelhorst, C. W. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca: fluxes. Proc. Natl. Acad. Sci. USA 91:6569-6573; 1994.
45. Onishi, Y.; Azuma, Y.; Sato, Y.; Mizuno, Y.; Tadakuma, T.; Kizaki, H. Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim. Biophys. Acta 1175:147-154; 1993.
46. Pushkareva, M.; Obeid, L. M.; Hannun, Y. A. Ceramide: An endogenous regulator of apoptosis and growth suppression. Imrriunol. Today 16:294-297; 1995.
47. McDonnell, T. J.; Korsmeyer, S. J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the 1(14:18). Nature 349:254-256; 1991.
48. Merlino, G. Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. Semin. Cancer Biol. 5:13-20; 1994.
49. Fujii, S.; Nanbu, Y.; Nonogaki, H.; Konishi, I.; Mori, T.; Masutani, H.; Yodoi, J. Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium. Cancer 68:1583-1591; 1991.
50. Kawahara, N.; Tanaka, T.; Yokomizo, A.; Nanri, H.; Ono, M.; Wada, M.; Kohno, K.; Takenaka, K.; Sugimachi, K.; Kuwano, M. Enhanced coexpression of thioredixin and high mobility group protein 1 genes in human hepatocellular carci-
51. noma and the possible association with decreased sensitivity tocisplatin. Cancer Res. 56:5330-5333; 1996.
52. Wollman, E. E.; d'Auriol, L.; Rimsky, L.; Shaw, A.; Jacquot, J.; Wingfield, P.; Graber, P.; Dessarps, F.; Robin, P.; Galibert, F.; Bertoglio, J.; Fradelizi, D. Cloning and expression of cDNA for human thioredoxin. J. Biol. Chem. 263: 15506-15512; 1988.
53. Qin, J.; Clore, G.; Gronenborn, A. The high-resolution threedimensional solution structures of the oxidized and reduced state of human thioredoxin. Structure 2:502-522; 1994.
54. Kumar, S.; Bjornstedt, M.; Holmgren, A. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur. J. Biochem. 207:435-439; 1992.
55. Andersson, C. M.; Brattsand, R.; Hallberg, A.; Engman, L.; Persson, J.; Moldeus, P.; Cotgreave, I. Diaryl tellurides as inhibitors of lipid peroxidation in biological and chemical systems. Free Radie. Res. 20:401-410; 1994.